journal article Open Access Mar 01, 2025

Cancer-Associated Fibroblasts in Intrahepatic Cholangiocarcinoma

View at Publisher Save 10.1016/j.ajpath.2024.07.009
Topics

No keywords indexed for this article. Browse by subject →

References
201
[1]
Kendall "Anatomical, histomorphological and molecular classification of cholangiocarcinoma" Liver Int (2019) 10.1111/liv.14093
[2]
Sirica "Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression" Adv Cancer Res (2021) 10.1016/bs.acr.2020.10.005
[3]
Vijgen "Pathology of intrahepatic cholangiocarcinoma" Hepatobiliary Surg Nutr (2017) 10.21037/hbsn.2016.11.04
[4]
Sirica "Desmoplastic stroma and cholangiocarcinoma: clinical implications and therapeutic targeting" Hepatology (2014) 10.1002/hep.26762
[5]
Brindley "Cholangiocarcinoma" Nat Rev Dis Primers (2021) 10.1038/s41572-021-00300-2
[6]
Sirica "Intrahepatic cholangiocarcinoma: continuing challenges and translational advances" Hepatology (2019) 10.1002/hep.30289
[7]
Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma

Min Zhang, Hui Yang, Lingfei Wan et al.

Journal of Hepatology 2020 10.1016/j.jhep.2020.05.039
[8]
Affò "Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations" Cancer Cell (2021) 10.1016/j.ccell.2021.03.012
[9]
Sirica "The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma" Nat Rev Gastroenterol Hepatol (2011) 10.1038/nrgastro.2011.222
[10]
Kajiyama "The significance of stromal desmoplasia in intrahepatic cholangiocarcinoma: a special reference of 'scirrhous-type' and 'nonscirrhous-type' growth" Am J Surg Pathol (1999) 10.1097/00000478-199908000-00006
[11]
Tothill "Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome" Clin Cancer Res (2008) 10.1158/1078-0432.ccr-08-0196
[12]
DeClerck "Desmoplasia: a response or a niche?" Cancer Discov (2012) 10.1158/2159-8290.cd-12-0348
[13]
Whatcott "Desmoplasia in primary tumors and metastatic lesions of pancreatic cancer" Clin Cancer Res (2015) 10.1158/1078-0432.ccr-14-1051
[14]
Kojima "Prognostic impact of desmoplastic reaction evaluation for intrahepatic cholangiocarcinoma" Anticancer Res (2020) 10.21873/anticanres.14476
[15]
Guedj "Prognostic value of desmoplastic stroma in intrahepatic cholangiocarcinoma" Mod Pathol (2021) 10.1038/s41379-020-00656-y
[16]
Mertens "Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma" Cancer Res (2013) 10.1158/0008-5472.can-12-2130
[17]
Jiang "Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix" J Clin Invest (2020) 10.1172/jci136760
[18]
Montori "Cancer-associated fibroblasts in cholangiocarcinoma: current knowledge and possible implications for therapy" J Clin Med (2022) 10.3390/jcm11216498
[19]
Cholangiocarcinoma — novel biological insights and therapeutic strategies

Sumera I. Ilyas, Silvia Affo, Lipika Goyal et al.

Nature Reviews Clinical Oncology 2023 10.1038/s41571-023-00770-1
[20]
Luo "Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment" Nat Commun (2022) 10.1038/s41467-022-34395-2
[21]
Martin-Serrano "Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications" Gut (2023) 10.1136/gutjnl-2021-326514
[22]
Augsten "Cancer-associated fibroblasts as another polarized cell type of the tumor microenvironment" Front Oncol (2014) 10.3389/fonc.2014.00062
[23]
Chen "Clinical and therapeutic relevance of cancer-associated fibroblasts" Nat Rev Clin Oncol (2021) 10.1038/s41571-021-00546-5
[24]
Fabris "The tumor microenvironment in cholangiocarcinoma progression" Hepatology (2021) 10.1002/hep.31410
[25]
Cantallops Vilà "Heterogeneity, crosstalk, and targeting of cancer-associated fibroblasts in cholangiocarcinoma" Hepatology (2024) 10.1097/hep.0000000000000206
[26]
Banales "Cholangiocarcinoma 2020: the next horizon in mechanisms and management" Nat Rev Gastroenterol Hepatol (2020) 10.1038/s41575-020-0310-z
[27]
Cancer-associated fibroblasts in desmoplastic tumors: emerging role of integrins

Cédric Zeltz, Irina Primac, Pugazendhi Erusappan et al.

Seminars in Cancer Biology 2020 10.1016/j.semcancer.2019.08.004
[28]
Ravichandra "Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma progression and therapeutic resistance" Adv Cancer Res (2022) 10.1016/bs.acr.2022.01.009
[29]
Ying "Cancer-associated fibroblasts in hepatocellular carcinoma and cholangiocarcinoma" Cell Mol Gastroenterol Hepatol (2023) 10.1016/j.jcmgh.2023.01.006
[30]
Goncalves-Ribeiro "Carcinoma-associated fibroblasts affect sensitivity to oxaliplatin and 5FU in colorectal cancer cells" Oncotarget (2016) 10.18632/oncotarget.11121
[31]
Brivio "Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness" World J Hepatol (2017) 10.4254/wjh.v9.i9.455
[32]
Sirica "Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma" Curr Opin Gastroenterol (2011) 10.1097/mog.0b013e32834405c3
[33]
Sirica "A novel "patient-like" model of cholangiocarcinoma progression based on bile duct inoculation of tumorigenic rat cholangiocyte cell lines" Hepatology (2008) 10.1002/hep.22088
[34]
Manzanares "Overexpression of periostin and distinct mesothelin forms predict malignant progression in a rat cholangiocarcinoma model" Hepatol Commun (2018) 10.1002/hep4.1131
[35]
Berdiel-Acer "Differences between CAFs and their paired NCF from adjacent colonic mucosa reveal functional heterogeneity of CAFs, providing prognostic information" Mol Oncol (2014) 10.1016/j.molonc.2014.04.006
[36]
Su "CD10(+)GPR77(+) cancer-associated fibroblasts promote cancer formation and chemoresistance by sustaining cancer stemness" Cell (2018) 10.1016/j.cell.2018.01.009
[37]
Zhang "Tumor microenvironment-derived NRG1 promotes antiandrogen resistance in prostate cancer" Cancer Cell (2020) 10.1016/j.ccell.2020.06.005
[38]
Francescone "Netrin G1 promotes pancreatic tumorigenesis through cancer-associated fibroblast-driven nutritional support and immunosuppression" Cancer Discov (2021) 10.1158/2159-8290.cd-20-0775
[39]
Ozdemir "Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival" Cancer Cell (2015) 10.1016/j.ccell.2015.11.002
[40]
Rhim "Stanger BZ: Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma" Cancer Cell (2014) 10.1016/j.ccr.2014.04.021
[41]
Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology

Ingmar Mederacke, Christine C. Hsu, Juliane S. Troeger et al.

Nature Communications 2013 10.1038/ncomms3823
[42]
Friend or foe? The elusive role of hepatic stellate cells in liver cancer

Bruno Cogliati, Chittampalli N. Yashaswini, Shuang Wang et al.

Nature Reviews Gastroenterology & Hepatology 2023 10.1038/s41575-023-00821-z
[43]
The Origin and Fate of Liver Myofibroblasts

Hyun Young Kim, Sadatsugu Sakane, Alvaro Eguileor et al.

Cellular and Molecular Gastroenterology and Hepato... 2024 10.1016/j.jcmgh.2023.09.008
[44]
Puche "Hepatic stellate cells and liver fibrosis" Compr Physiol (2013) 10.1002/j.2040-4603.2013.tb00529.x
[45]
Molecular and cellular mechanisms of liver fibrosis and its regression

Tatiana Kisseleva, David Brenner

Nature Reviews Gastroenterology & Hepatology 2021 10.1038/s41575-020-00372-7
[46]
Karin "The characteristics of activated portal fibroblasts/myofibroblasts in liver fibrosis" Differentiation (2016) 10.1016/j.diff.2016.07.001
[47]
Affò "The role of cancer-associated fibroblasts and fibrosis in liver cancer" Annu Rev Pathol (2017) 10.1146/annurev-pathol-052016-100322
[48]
Zhang "Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials" Mol Cancer (2023) 10.1186/s12943-023-01860-5
[49]
Cadamuro "Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma" Hepatology (2013) 10.1002/hep.26384
[50]
Cadamuro "Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma" J Hepatol (2019) 10.1016/j.jhep.2018.12.004

Showing 50 of 201 references

Cited By
10
Seminars in Nuclear Medicine
Metrics
10
Citations
201
References
Details
Published
Mar 01, 2025
Vol/Issue
195(3)
Pages
378-396
License
View
Funding
European Commission Award: 101077312
Cancer Prevention and Research Institute of Texas Award: RP230204
Federación Española de Enfermedades Raras
Agencia Estatal de Investigación
MINISTERIO DE CIENCIA E INNOVACIÓN
Cite This Article
Silvia Affὸ, Laura Sererols-Viñas, Gemma Garcia-Vicién, et al. (2025). Cancer-Associated Fibroblasts in Intrahepatic Cholangiocarcinoma. The American Journal of Pathology, 195(3), 378-396. https://doi.org/10.1016/j.ajpath.2024.07.009
Related

You May Also Like

Ovarian Cancer Development and Metastasis

Ernst Lengyel · 2010

1,392 citations

Openings between Defective Endothelial Cells Explain Tumor Vessel Leakiness

Hiroya Hashizume, Peter Baluk · 2000

1,343 citations

Aligned Collagen Is a Prognostic Signature for Survival in Human Breast Carcinoma

Matthew W. Conklin, Jens C. Eickhoff · 2011

1,148 citations

Angiosarcomas Express Mixed Endothelial Phenotypes of Blood and Lymphatic Capillaries

Silvana Breiteneder-Geleff, Afschin Soleiman · 1999

883 citations

Onset of Maternal Arterial Blood Flow and Placental Oxidative Stress

Eric Jauniaux, Adrian L. Watson · 2000

872 citations